Michelle Berrey Insider Profile

4 Followers
Michelle Berrey, President & CEO, Director at Chimerix, holds 80.14K shares in Intercept Pharma (Ticker: ICPT), holds 424.94K shares in Chimerix (Ticker: CMRX), holds ― shares in Ocean Biomedical (Ticker: OCEA).
tipranks
Michelle Berrey

Michelle Berrey
Chimerix (CMRX)
President & CEO, Director

Ranked #13,684 out of 99,218 Corporate Insiders

Profitable Transactions

40%
4 out of 10 Profitable Transactions

Average Return

+13.20%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$421K
100.00%
0.00%
A breakdown of Michelle Berrey's holdings

Insider Roles

Chimerix
(CMRX)
President & CEO, Director
Ocean Biomedical
(OCEA)
Director
Roles that Michelle Berrey holds in companies

Most Profitable Insider Trade

Stock:
Chimerix
(CMRX)
Rating:Informative Buy
Date:May 22, 2014 - May 22, 2015
Return:+151.10%
The most profitable trade made by Michelle Berrey

Michelle Berrey's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Chimerix
Jun 14, 2018
President & CEO, Director
Informative Buy
45.00K
$420.69K
ICPT
Intercept Pharma
Sep 18, 2023
Uninformative Sell
14.42K
$1.52M
Ocean Biomedical
Director
List of latest transactions for each holding click on a transaction to see Michelle Berrey's performance on stock

Michelle Berrey insider profile FAQ

What is the percentage of profitable transactions made by Michelle Berrey?
The percentage of profitable transactions made by Michelle Berrey is 40%.
    What is the average return per transaction made by Michelle Berrey?
    The average return per transaction made by Michelle Berrey is 13.20%.
      What stocks does Michelle Berrey hold?
      Michelle Berrey holds: CMRX, ICPT, OCEA stocks.
        What was Michelle Berrey’s latest transaction?
        Michelle Berrey latest transaction was an Uninformative Sell of $14.42K.
          What was Michelle Berrey's most profitable transaction?
          Michelle Berrey’s most profitable transaction was an Informative Buy of CMRX stock on May 22, 2014. The return on the trade was 151.10%.
            What is Michelle Berrey's role in Chimerix?
            Michelle Berrey's role in Chimerix is President & CEO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.